1. Home
  2. ARCT vs DHC Comparison

ARCT vs DHC Comparison

Compare ARCT & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • DHC
  • Stock Information
  • Founded
  • ARCT 2013
  • DHC 1998
  • Country
  • ARCT United States
  • DHC United States
  • Employees
  • ARCT N/A
  • DHC N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • DHC Real Estate Investment Trusts
  • Sector
  • ARCT Health Care
  • DHC Real Estate
  • Exchange
  • ARCT Nasdaq
  • DHC Nasdaq
  • Market Cap
  • ARCT 298.3M
  • DHC 757.5M
  • IPO Year
  • ARCT N/A
  • DHC N/A
  • Fundamental
  • Price
  • ARCT $13.78
  • DHC $3.75
  • Analyst Decision
  • ARCT Strong Buy
  • DHC Hold
  • Analyst Count
  • ARCT 8
  • DHC 3
  • Target Price
  • ARCT $52.83
  • DHC $4.50
  • AVG Volume (30 Days)
  • ARCT 484.1K
  • DHC 936.8K
  • Earning Date
  • ARCT 08-04-2025
  • DHC 07-31-2025
  • Dividend Yield
  • ARCT N/A
  • DHC 1.07%
  • EPS Growth
  • ARCT N/A
  • DHC N/A
  • EPS
  • ARCT N/A
  • DHC N/A
  • Revenue
  • ARCT $143,680,000.00
  • DHC $1,511,515,000.00
  • Revenue This Year
  • ARCT N/A
  • DHC $3.98
  • Revenue Next Year
  • ARCT $34.79
  • DHC $4.50
  • P/E Ratio
  • ARCT N/A
  • DHC N/A
  • Revenue Growth
  • ARCT 15.38
  • DHC 5.33
  • 52 Week Low
  • ARCT $8.04
  • DHC $2.00
  • 52 Week High
  • ARCT $25.88
  • DHC $4.24
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 57.25
  • DHC 67.68
  • Support Level
  • ARCT $12.65
  • DHC $3.50
  • Resistance Level
  • ARCT $14.09
  • DHC $3.82
  • Average True Range (ATR)
  • ARCT 0.93
  • DHC 0.17
  • MACD
  • ARCT 0.05
  • DHC -0.01
  • Stochastic Oscillator
  • ARCT 60.04
  • DHC 72.55

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.

Share on Social Networks: